[How to approach intravitreal injections during this COVID-19 pandemic ?]
Identifieur interne : 000161 ( Main/Exploration ); précédent : 000160; suivant : 000162[How to approach intravitreal injections during this COVID-19 pandemic ?]
Auteurs : L. Kodjikian [France]Source :
- Journal francais d'ophtalmologie [ 1773-0597 ] ; 2020.
Descripteurs français
- KwdFr :
- Betacoronavirus (MeSH), Dégénérescence de la rétine (traitement médicamenteux), Dégénérescence maculaire (traitement médicamenteux), Humains (MeSH), Infections à coronavirus (prévention et contrôle), Infections à coronavirus (épidémiologie), Injections intravitréennes (méthodes), Injections intravitréennes (normes), Néovascularisation rétinienne (traitement médicamenteux), Pandémies (prévention et contrôle), Pneumopathie virale (prévention et contrôle), Pneumopathie virale (épidémiologie), Rétinopathie diabétique (imagerie diagnostique), Tomographie par cohérence optique (MeSH), Urgences (MeSH).
- MESH :
- imagerie diagnostique : Rétinopathie diabétique.
- méthodes : Injections intravitréennes.
- normes : Injections intravitréennes.
- prévention et contrôle : Infections à coronavirus, Pandémies, Pneumopathie virale.
- traitement médicamenteux : Dégénérescence de la rétine, Dégénérescence maculaire, Néovascularisation rétinienne.
- épidémiologie : Infections à coronavirus, Pneumopathie virale.
- Betacoronavirus, Humains, Tomographie par cohérence optique, Urgences.
English descriptors
- KwdEn :
- Betacoronavirus (MeSH), Coronavirus Infections (epidemiology), Coronavirus Infections (prevention & control), Diabetic Retinopathy (diagnostic imaging), Emergencies (MeSH), Humans (MeSH), Intravitreal Injections (methods), Intravitreal Injections (standards), Macular Degeneration (drug therapy), Pandemics (prevention & control), Pneumonia, Viral (epidemiology), Pneumonia, Viral (prevention & control), Retinal Degeneration (drug therapy), Retinal Neovascularization (drug therapy), Tomography, Optical Coherence (MeSH).
- MESH :
- diagnostic imaging : Diabetic Retinopathy.
- drug therapy : Macular Degeneration, Retinal Degeneration, Retinal Neovascularization.
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- methods : Intravitreal Injections.
- prevention & control : Coronavirus Infections, Pandemics, Pneumonia, Viral.
- standards : Intravitreal Injections.
- Betacoronavirus, Emergencies, Humans, Tomography, Optical Coherence.
DOI: 10.1016/j.jfo.2020.04.019
PubMed: 32451137
PubMed Central: PMC7198140
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[How to approach intravitreal injections during this COVID-19 pandemic ?]</title>
<author><name sortKey="Kodjikian, L" sort="Kodjikian, L" uniqKey="Kodjikian L" first="L" last="Kodjikian">L. Kodjikian</name>
<affiliation wicri:level="3"><nlm:affiliation>Service d'ophtalmologie, CHU Croix-Rousse, 103, grande rue de la Croix-Rousse, 69004 Lyon, France. Electronic address: kodjikian.laurent@wanadoo.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'ophtalmologie, CHU Croix-Rousse, 103, grande rue de la Croix-Rousse, 69004 Lyon</wicri:regionArea>
<placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32451137</idno>
<idno type="pmid">32451137</idno>
<idno type="doi">10.1016/j.jfo.2020.04.019</idno>
<idno type="pmc">PMC7198140</idno>
<idno type="wicri:Area/Main/Corpus">001125</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001125</idno>
<idno type="wicri:Area/Main/Curation">001125</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001125</idno>
<idno type="wicri:Area/Main/Exploration">001125</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[How to approach intravitreal injections during this COVID-19 pandemic ?]</title>
<author><name sortKey="Kodjikian, L" sort="Kodjikian, L" uniqKey="Kodjikian L" first="L" last="Kodjikian">L. Kodjikian</name>
<affiliation wicri:level="3"><nlm:affiliation>Service d'ophtalmologie, CHU Croix-Rousse, 103, grande rue de la Croix-Rousse, 69004 Lyon, France. Electronic address: kodjikian.laurent@wanadoo.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'ophtalmologie, CHU Croix-Rousse, 103, grande rue de la Croix-Rousse, 69004 Lyon</wicri:regionArea>
<placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal francais d'ophtalmologie</title>
<idno type="eISSN">1773-0597</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (MeSH)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Coronavirus Infections (prevention & control)</term>
<term>Diabetic Retinopathy (diagnostic imaging)</term>
<term>Emergencies (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Intravitreal Injections (methods)</term>
<term>Intravitreal Injections (standards)</term>
<term>Macular Degeneration (drug therapy)</term>
<term>Pandemics (prevention & control)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Pneumonia, Viral (prevention & control)</term>
<term>Retinal Degeneration (drug therapy)</term>
<term>Retinal Neovascularization (drug therapy)</term>
<term>Tomography, Optical Coherence (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Betacoronavirus (MeSH)</term>
<term>Dégénérescence de la rétine (traitement médicamenteux)</term>
<term>Dégénérescence maculaire (traitement médicamenteux)</term>
<term>Humains (MeSH)</term>
<term>Infections à coronavirus (prévention et contrôle)</term>
<term>Infections à coronavirus (épidémiologie)</term>
<term>Injections intravitréennes (méthodes)</term>
<term>Injections intravitréennes (normes)</term>
<term>Néovascularisation rétinienne (traitement médicamenteux)</term>
<term>Pandémies (prévention et contrôle)</term>
<term>Pneumopathie virale (prévention et contrôle)</term>
<term>Pneumopathie virale (épidémiologie)</term>
<term>Rétinopathie diabétique (imagerie diagnostique)</term>
<term>Tomographie par cohérence optique (MeSH)</term>
<term>Urgences (MeSH)</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Diabetic Retinopathy</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Macular Degeneration</term>
<term>Retinal Degeneration</term>
<term>Retinal Neovascularization</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr"><term>Rétinopathie diabétique</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Intravitreal Injections</term>
</keywords>
<keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Injections intravitréennes</term>
</keywords>
<keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Injections intravitréennes</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pandemics</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pandémies</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Intravitreal Injections</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Dégénérescence de la rétine</term>
<term>Dégénérescence maculaire</term>
<term>Néovascularisation rétinienne</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term>
<term>Emergencies</term>
<term>Humans</term>
<term>Tomography, Optical Coherence</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Betacoronavirus</term>
<term>Humains</term>
<term>Tomographie par cohérence optique</term>
<term>Urgences</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32451137</PMID>
<DateCompleted><Year>2020</Year>
<Month>06</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>06</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1773-0597</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>43</Volume>
<Issue>6</Issue>
<PubDate><Year>2020</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Journal francais d'ophtalmologie</Title>
<ISOAbbreviation>J Fr Ophtalmol</ISOAbbreviation>
</Journal>
<ArticleTitle>[How to approach intravitreal injections during this COVID-19 pandemic ?]</ArticleTitle>
<Pagination><MedlinePgn>539-540</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0181-5512(20)30183-2</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jfo.2020.04.019</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kodjikian</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Service d'ophtalmologie, CHU Croix-Rousse, 103, grande rue de la Croix-Rousse, 69004 Lyon, France. Electronic address: kodjikian.laurent@wanadoo.fr.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>fre</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D017065">Practice Guideline</PublicationType>
</PublicationTypeList>
<VernacularTitle>Quelle conduite à tenir adopter vis à vis des injections intravitréennes (IVT) dans cette période d’épidémie au Covid-19 – SARS-CoV-2 ?</VernacularTitle>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>05</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>France</Country>
<MedlineTA>J Fr Ophtalmol</MedlineTA>
<NlmUniqueID>7804128</NlmUniqueID>
<ISSNLinking>0181-5512</ISSNLinking>
</MedlineJournalInfo>
<SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003930" MajorTopicYN="N">Diabetic Retinopathy</DescriptorName>
<QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004630" MajorTopicYN="N">Emergencies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058449" MajorTopicYN="N">Intravitreal Injections</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
<QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008268" MajorTopicYN="N">Macular Degeneration</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012162" MajorTopicYN="N">Retinal Degeneration</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015861" MajorTopicYN="N">Retinal Neovascularization</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D041623" MajorTopicYN="N">Tomography, Optical Coherence</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>04</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>04</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>5</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>6</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>5</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32451137</ArticleId>
<ArticleId IdType="pii">S0181-5512(20)30183-2</ArticleId>
<ArticleId IdType="doi">10.1016/j.jfo.2020.04.019</ArticleId>
<ArticleId IdType="pmc">PMC7198140</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>France</li>
</country>
<region><li>Auvergne-Rhône-Alpes</li>
<li>Rhône-Alpes</li>
</region>
<settlement><li>Lyon</li>
</settlement>
</list>
<tree><country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Kodjikian, L" sort="Kodjikian, L" uniqKey="Kodjikian L" first="L" last="Kodjikian">L. Kodjikian</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000161 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000161 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidFranceV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:32451137 |texte= [How to approach intravitreal injections during this COVID-19 pandemic ?] }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32451137" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a CovidFranceV1
This area was generated with Dilib version V0.6.37. |